MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituents

Bioorg Med Chem. 2006 Dec 15;14(24):8506-18. doi: 10.1016/j.bmc.2006.08.037. Epub 2006 Sep 18.

Abstract

A series of 4-oxo-4H-pyrido[1,2-a]pyrimidine derivatives, derivatized at the 2-position with aromatic substituents, were synthesized by the Suzuki cross-coupling method and evaluated for their ability to potentiate the activity of the fluoroquinolone levofloxacin (LVFX) and the anti-pseudomonas beta-lactam aztreonam (AZT) in Pseudomonas aeruginosa. By incorporating hydrophilic substituents onto the aryl nucleus, we found a morpholine analogue that possessed improved solubility, retained activity in vitro, and displayed potentiation activity in vivo in a rat model of P. aeruginosa pneumonia.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Aztreonam / chemistry
  • Aztreonam / pharmacology
  • Bacterial Outer Membrane Proteins / antagonists & inhibitors*
  • Levofloxacin
  • Lung / drug effects
  • Lung / microbiology
  • Membrane Transport Proteins
  • Microbial Sensitivity Tests
  • Ofloxacin / chemistry
  • Pseudomonas aeruginosa / drug effects*
  • Pyrimidines / chemical synthesis
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Anti-Bacterial Agents
  • Bacterial Outer Membrane Proteins
  • Membrane Transport Proteins
  • MexA protein, Pseudomonas aeruginosa
  • MexB protein, Pseudomonas aeruginosa
  • OprM protein, Pseudomonas aeruginosa
  • Pyrimidines
  • Levofloxacin
  • Ofloxacin
  • Aztreonam